TUBG1

Chr 17

tubulin gamma 1

Also known as: CDCBM4, GCP-1, TUBG, TUBGCP1

This gene encodes a member of the tubulin superfamily. The encoded protein localizes to the centrosome where it binds to microtubules as part of a complex referred to as the gamma-tubulin ring complex. The protein mediates microtubule nucleation and is required for microtubule formation and progression of the cell cycle. A pseudogene of this gene is found on chromosome 7. [provided by RefSeq, Jan 2009]

GeneReviewsResearchGenerating clinical summary…
DNmechanismLOEUF 0.52
VCEP Guidelines: Brain MalformationsReleased
View SpecificationsClinGen Panel
Clinical SummaryTUBG1
🧬
Gene-Disease Validity (ClinGen)
lissencephaly spectrum disorders · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 71 VUS of 227 total submissions
📖
GeneReview available — TUBG1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.52LOEUF
pLI 0.129
Z-score 3.27
OE 0.26 (0.140.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
4.16Z-score
OE missense 0.30 (0.250.36)
82 obs / 276.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.26 (0.140.52)
00.351.4
Missense OE?0.30 (0.250.36)
00.61.4
Synonymous OE?0.99
01.21.6
LoF obs/exp: 6 / 22.9Missense obs/exp: 82 / 276.4Syn Z: 0.07
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongTUBG1-related posteriorly predominant pachygyria and severe microcephalyOTHERAD

This gene — mechanism propensity

DN
0.7327th %ile
GOF
0.5464th %ile
LOF
0.3065th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNIn view of the fact that both KIF2A alleles are expressed in patient fibroblasts (Supplementary Fig. 4b) and the KIF2A molecule functions as a dimer22, our in vitro and in vivo data are consistent with a dominant-negative effect of these mutations.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 23603762

ClinVar Variant Classifications

227 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic12
VUS71
Likely Benign101
Benign26
Conflicting4
2
Pathogenic
12
Likely Pathogenic
71
VUS
101
Likely Benign
26
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
0
0
2
Likely Pathogenic
1
11
0
0
12
VUS
5
53
11
2
71
Likely Benign
1
1
44
55
101
Benign
0
2
17
7
26
Conflicting
4
Total7697264216

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap TUBG1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TUBG1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →